{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-008808","form_type":"8-K","ticker":"ELTP","cik":"0001053369","company_name":"ELITE PHARMACEUTICALS INC /NV/","filed_at":"2025-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.817673+00:00","generated_at":"2026-05-25T16:46:05.271364+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Elite Pharmaceuticals ships first product from new FDA-approved expanded campus","bullets":["First lot of finished product shipped from new facility at 144 Ludlow Avenue, Northvale, NJ.","New packaging line runs at ~120 bottles per minute, adding packaging, inventory and warehouse space.","Expansion converts existing packaging space into additional manufacturing suites, boosting production capacity.","Company says new facility positions it to meet projected packaging demand for at least the next five years."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-008808","json":"https://secwatch.observer/filing/0001493152-25-008808.json","markdown":"https://secwatch.observer/filing/0001493152-25-008808.md","text":"https://secwatch.observer/filing/0001493152-25-008808.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225008808/0001493152-25-008808-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225008808/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T16:46:05.271364+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}